Association of cancer characteristics with disability status and timing of onset among working-age cancer survivors
JNCI Cancer Spectrum · 2026
DOI: 10.1093/jncics/pkag091 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2026. Verfasst von Hyo Jung Tak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Research and Administration, University of Nebraska Medical Center, Omaha, NE, United States. Hauptthemen laut MEDLINE: Neoplasms, Persons with Disabilities, Cancer Survivors, Insurance, Disability. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute at the National Institutes of Health.
Abstract (Originalsprache)
Background
Numerous studies examine the impact of cancer and disability on health-care use, financial toxicity, and health outcomes but not the relationship between cancer and disability. This study investigates whether and how cancer characteristics are associated with disability status (Social Security Disability Insurance) and timing of onset among prime working-age cancer survivors.
Methods
We used the 1999 to 2022 Surveillance, Epidemiology, and End Results file linked with Medicare data. Outcome was a categorical variable indicating no disability, disability onset ≥2 years and 0-<2 years before cancer diagnosis, and 0-<2 years and ≥2 years after diagnosis. Primary independent variables were 16 categories of cancer sites and stage at diagnosis. We employed a multivariable multinomial probit regression model, adjusting for patient and neighborhood characteristics, overall and by 5-year survival.
Results
Of the total sample (n = 97 642), 62.2%, 22.4%, and 15.4% had no, precancer, and postcancer disability, respectively. Likelihood of disability and timing of disability onset differed by cancer sites. Compared with prostate cancer survivors (lowest prevalence of disability), adjusted predicted probability of having disability ≥2 years before diagnosis was higher by 0.46 (95% CI = 0.43 to 0.49) among liver cancer survivors, whereas having disability <2 years after diagnosis was higher by 0.29 (95% CI = 0.27 to 0.32) among brain cancer survivors. Nearly all <5-year cancer survivors had disability, and the patterns of association varied significantly by 5-year survival.
Conclusions
Clinically assessed disability is strongly associated with specific cancer sites. These findings may point to strategies to improve efficiency of cancer prevention and care, reducing untoward impacts on survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health Services Research and Administration, University of Nebraska Medical Center, Omaha, NE, United States.
- Department of Radiation Oncology, UCLA, Los Angeles, CA, United States.
- Department of Cardiovascular Medicine, Baystate Medical Center and Division of Cardiovascular Medicine, University of Massachusetts-Baystate, Springfield, MA, United States.
- Department of Economics, University of Chicago, Chicago, IL, United States.
ORCID-Profile: Hyo Jung Tak, Ya-Chen Tina Shih
Förderung
- NCI NIH HHS
- National Cancer Institute at the National Institutes of Health
Zitieren
APA
Tak, H. J., Shih, Y. T., Grimm, B. L., Goldsweig, A. M., Lee, M. S., & Horner, R. D. (2026). Association of cancer characteristics with disability status and timing of onset among working-age cancer survivors. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag091
Vancouver
Tak HJ, Shih YT, Grimm BL, Goldsweig AM, Lee MS, Horner RD. Association of cancer characteristics with disability status and timing of onset among working-age cancer survivors. JNCI Cancer Spectrum. 2026. doi:10.1093/jncics/pkag091
BibTeX
@article{Tak2026,
author = {Tak, Hyo Jung and Shih, Ya-Chen Tina and Grimm, Brandon L and Goldsweig, Andrew M and Lee, Min Sok and Horner, Ronnie D},
title = {Association of cancer characteristics with disability status and timing of onset among working-age cancer survivors},
journal = {JNCI Cancer Spectrum},
year = {2026},
doi = {10.1093/jncics/pkag091}
}
EUVIMED